Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER
about
Refractory overactive bladder: a common problem?Comparison of solifenacin and fesoterodine in treatment of overactive bladder.Efficacy and safety of fesoterodine treatment for overactive bladder symptoms in elderly women with and without hypertension.Effects of electroacupuncture on overactive bladder refractory to anticholinergics: a single-blind randomised controlled trial.Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
P2860
Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@ast
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@en
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@nl
type
label
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@ast
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@en
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@nl
prefLabel
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@ast
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@en
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@nl
P2093
P2860
P356
P1476
Efficacy and safety of fesoter ...... mal response to tolterodine ER
@en
P2093
Assessment of Fesoterodine after Tolterodine ER (AFTER) Study Group
D Scholfield
M Carlsson
S A Kaplan
S Herschorn
P2860
P304
P356
10.1111/IJCP.12464
P577
2014-06-04T00:00:00Z